Annual Interest Expense
N/A
December 31, 2022
Summary
- BLCM annual interest expense is not available.
Performance
BLCM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
N/A
September 1, 2023
Summary
- BLCM quarterly interest expense is not available.
Performance
BLCM Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
September 1, 2023
Summary
- BLCM TTM interest expense is not available.
Performance
BLCM TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
BLCM Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
BLCM Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Bellicum Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $0.00(-100.0%) | $191.00 K(-79.1%) |
| Jun 2021 | - | $1000.00(-75.0%) | $916.00 K(-45.4%) |
| Mar 2021 | - | $4000.00(-97.8%) | $1.68 M(-36.9%) |
| Dec 2020 | $2.66 M(-37.9%) | $186.00 K(-74.3%) | $2.66 M(-24.4%) |
| Sep 2020 | - | $725.00 K(-5.0%) | $3.52 M(-9.1%) |
| Jun 2020 | - | $763.00 K(-22.5%) | $3.87 M(-7.7%) |
| Mar 2020 | - | $985.00 K(-5.6%) | $4.20 M(-2.0%) |
| Dec 2019 | $4.28 M(+1.9%) | $1.04 M(-3.3%) | $4.28 M(-1.0%) |
| Sep 2019 | - | $1.08 M(-0.8%) | $4.32 M(+0.3%) |
| Jun 2019 | - | $1.09 M(+1.7%) | $4.31 M(+1.0%) |
| Mar 2019 | - | $1.07 M(-1.5%) | $4.27 M(+1.6%) |
| Dec 2018 | $4.20 M(+14.4%) | $1.09 M(+2.0%) | $4.20 M(+3.0%) |
| Sep 2018 | - | $1.06 M(+1.9%) | $4.08 M(+1.4%) |
| Jun 2018 | - | $1.04 M(+4.2%) | $4.02 M(+1.7%) |
| Mar 2018 | - | $1.00 M(+3.9%) | $3.95 M(+7.7%) |
| Dec 2017 | $3.67 M | $965.00 K(-4.5%) | $3.67 M(+9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $1.01 M(+3.5%) | $3.34 M(+17.4%) |
| Jun 2017 | - | $976.00 K(+35.4%) | $2.85 M(+20.8%) |
| Mar 2017 | - | $721.00 K(+13.2%) | $2.36 M(+34.0%) |
| Dec 2016 | $1.76 M(>+9900.0%) | $637.00 K(+23.7%) | $1.76 M(+56.7%) |
| Sep 2016 | - | $515.00 K(+6.0%) | $1.12 M(+84.7%) |
| Jun 2016 | - | $486.00 K(+298.4%) | $608.00 K(+398.4%) |
| Mar 2016 | - | $122.00 K(>+9900.0%) | $122.00 K(-93.1%) |
| Dec 2015 | $12.00 K(-99.3%) | - | - |
| Jun 2015 | - | $0.00(0.0%) | $1.76 M(-0.6%) |
| Mar 2015 | - | $0.00(-100.0%) | $1.77 M(-0.9%) |
| Dec 2014 | $1.79 M(+3411.8%) | $1.75 M(>+9900.0%) | $1.79 M(+3446.5%) |
| Sep 2014 | - | $11.00 K(0.0%) | $50.50 K(+27.8%) |
| Jun 2014 | - | $11.00 K(-31.3%) | $39.50 K(+38.6%) |
| Mar 2014 | - | $16.00 K(+28.0%) | $28.50 K(+128.0%) |
| Dec 2013 | $51.00 K(+3542.9%) | $12.50 K | $12.50 K |
| Dec 2012 | $1400.00 | - | - |
FAQ
- What is the all time high annual interest expense for Bellicum Pharmaceuticals?
- What is the all time high quarterly interest expense for Bellicum Pharmaceuticals?
- What is the all time high TTM interest expense for Bellicum Pharmaceuticals?
What is the all time high annual interest expense for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high annual interest expense is $4.28 M
What is the all time high quarterly interest expense for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high quarterly interest expense is $1.75 M
What is the all time high TTM interest expense for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high TTM interest expense is $4.32 M